Impaired Cognitive Flexibility With Preserved Learning in an Amyloid Precursor Protein Knock‐In Mouse Model of Amyloidopathy

ABSTRACT Alzheimer's disease is a debilitating neurodegenerative condition characterized by amyloid beta plaques and tau neurofibrillary tangles, which leads to progressive cognitive decline. Several new mouse models of fast amyloid deposition have been generated with compound mutations, but ho...

Full description

Saved in:
Bibliographic Details
Published inGenes, brain and behavior Vol. 24; no. 3; pp. e70024 - n/a
Main Authors Dumont, Julie R., Sheppard, Paul A. S., Fodor, Chris, Coto, M. Alexander, Yang, Sabrina, Saito, Takashi, Saido, Takaomi C., Rylett, R. Jane, Prado, Marco A. M., Bussey, Timothy J., Saksida, Lisa M., Prado, Vania F.
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.06.2025
John Wiley & Sons, Inc
Subjects
Online AccessGet full text
ISSN1601-1848
1601-183X
1601-183X
DOI10.1111/gbb.70024

Cover

Abstract ABSTRACT Alzheimer's disease is a debilitating neurodegenerative condition characterized by amyloid beta plaques and tau neurofibrillary tangles, which leads to progressive cognitive decline. Several new mouse models of fast amyloid deposition have been generated with compound mutations, but how these affect high‐level cognitive function is still not fully understood. Four cohorts of a second‐generation amyloid precursor protein knock‐in mouse model, AppNL‐G‐F/NL‐G‐F, which develops aggressive amyloidopathy, were compared with two different control groups that do not produce plaques (AppNL/NL and wildtype littermates), on touchscreen‐based tests of learning and cognitive flexibility. AppNL‐G‐F/NL‐G‐F mice learned to discriminate between two visual stimuli during the pairwise visual discrimination (PVD) task but were impaired when the reward contingencies were reversed (the PVR task). Analyses of the correction trials indicated perseverative behavior. One cohort was further tested on the touchscreen Extinction test, which isolates the ability to withhold responding to a previously rewarded stimulus. The AppNL‐G‐F/NL‐G‐F mice extinguished their responding no differently than the AppNL/NL control group. These results indicate that compound mutations in App driving fast accumulation of plaques in this mouse model impair cognitive flexibility and may serve as a preclinical target for putative therapeutic drugs. The amyloid precursor protein knock‐in mouse model of amyloidopathy (AppNL‐G‐F/NL‐G‐F) was assessed on touchscreen‐based learning and cognitive flexibility tasks in comparison with both AppNL/NL and wildtype littermate controls. AppNL‐G‐F/NL‐G‐F mice had impaired cognitive flexibility, intact learning, and AppNL/NL mice experienced considerable sex‐ and age‐related declines in cognitive flexibility.
AbstractList Alzheimer's disease is a debilitating neurodegenerative condition characterized by amyloid beta plaques and tau neurofibrillary tangles, which leads to progressive cognitive decline. Several new mouse models of fast amyloid deposition have been generated with compound mutations, but how these affect high‐level cognitive function is still not fully understood. Four cohorts of a second‐generation amyloid precursor protein knock‐in mouse model, App NL‐G‐F/NL‐G‐F , which develops aggressive amyloidopathy, were compared with two different control groups that do not produce plaques ( App NL/NL and wildtype littermates), on touchscreen‐based tests of learning and cognitive flexibility. App NL‐G‐F/NL‐G‐F mice learned to discriminate between two visual stimuli during the pairwise visual discrimination (PVD) task but were impaired when the reward contingencies were reversed (the PVR task). Analyses of the correction trials indicated perseverative behavior. One cohort was further tested on the touchscreen Extinction test, which isolates the ability to withhold responding to a previously rewarded stimulus. The App NL‐G‐F/NL‐G‐F mice extinguished their responding no differently than the App NL/NL control group. These results indicate that compound mutations in App driving fast accumulation of plaques in this mouse model impair cognitive flexibility and may serve as a preclinical target for putative therapeutic drugs.
ABSTRACT Alzheimer's disease is a debilitating neurodegenerative condition characterized by amyloid beta plaques and tau neurofibrillary tangles, which leads to progressive cognitive decline. Several new mouse models of fast amyloid deposition have been generated with compound mutations, but how these affect high‐level cognitive function is still not fully understood. Four cohorts of a second‐generation amyloid precursor protein knock‐in mouse model, AppNL‐G‐F/NL‐G‐F, which develops aggressive amyloidopathy, were compared with two different control groups that do not produce plaques (AppNL/NL and wildtype littermates), on touchscreen‐based tests of learning and cognitive flexibility. AppNL‐G‐F/NL‐G‐F mice learned to discriminate between two visual stimuli during the pairwise visual discrimination (PVD) task but were impaired when the reward contingencies were reversed (the PVR task). Analyses of the correction trials indicated perseverative behavior. One cohort was further tested on the touchscreen Extinction test, which isolates the ability to withhold responding to a previously rewarded stimulus. The AppNL‐G‐F/NL‐G‐F mice extinguished their responding no differently than the AppNL/NL control group. These results indicate that compound mutations in App driving fast accumulation of plaques in this mouse model impair cognitive flexibility and may serve as a preclinical target for putative therapeutic drugs. The amyloid precursor protein knock‐in mouse model of amyloidopathy (AppNL‐G‐F/NL‐G‐F) was assessed on touchscreen‐based learning and cognitive flexibility tasks in comparison with both AppNL/NL and wildtype littermate controls. AppNL‐G‐F/NL‐G‐F mice had impaired cognitive flexibility, intact learning, and AppNL/NL mice experienced considerable sex‐ and age‐related declines in cognitive flexibility.
Alzheimer's disease is a debilitating neurodegenerative condition characterized by amyloid beta plaques and tau neurofibrillary tangles, which leads to progressive cognitive decline. Several new mouse models of fast amyloid deposition have been generated with compound mutations, but how these affect high-level cognitive function is still not fully understood. Four cohorts of a second-generation amyloid precursor protein knock-in mouse model, App , which develops aggressive amyloidopathy, were compared with two different control groups that do not produce plaques (App and wildtype littermates), on touchscreen-based tests of learning and cognitive flexibility. App mice learned to discriminate between two visual stimuli during the pairwise visual discrimination (PVD) task but were impaired when the reward contingencies were reversed (the PVR task). Analyses of the correction trials indicated perseverative behavior. One cohort was further tested on the touchscreen Extinction test, which isolates the ability to withhold responding to a previously rewarded stimulus. The App mice extinguished their responding no differently than the App control group. These results indicate that compound mutations in App driving fast accumulation of plaques in this mouse model impair cognitive flexibility and may serve as a preclinical target for putative therapeutic drugs.
Alzheimer's disease is a debilitating neurodegenerative condition characterized by amyloid beta plaques and tau neurofibrillary tangles, which leads to progressive cognitive decline. Several new mouse models of fast amyloid deposition have been generated with compound mutations, but how these affect high‐level cognitive function is still not fully understood. Four cohorts of a second‐generation amyloid precursor protein knock‐in mouse model, App NL‐G‐F/NL‐G‐F , which develops aggressive amyloidopathy, were compared with two different control groups that do not produce plaques ( App NL/NL and wildtype littermates), on touchscreen‐based tests of learning and cognitive flexibility. App NL‐G‐F/NL‐G‐F mice learned to discriminate between two visual stimuli during the pairwise visual discrimination (PVD) task but were impaired when the reward contingencies were reversed (the PVR task). Analyses of the correction trials indicated perseverative behavior. One cohort was further tested on the touchscreen Extinction test, which isolates the ability to withhold responding to a previously rewarded stimulus. The App NL‐G‐F/NL‐G‐F mice extinguished their responding no differently than the App NL/NL control group. These results indicate that compound mutations in App driving fast accumulation of plaques in this mouse model impair cognitive flexibility and may serve as a preclinical target for putative therapeutic drugs. The amyloid precursor protein knock‐in mouse model of amyloidopathy ( App NL‐G‐F/NL‐G‐F ) was assessed on touchscreen‐based learning and cognitive flexibility tasks in comparison with both App NL/NL and wildtype littermate controls. App NL‐G‐F/NL‐G‐F mice had impaired cognitive flexibility, intact learning, and App NL/NL mice experienced considerable sex‐ and age‐related declines in cognitive flexibility.
Alzheimer's disease is a debilitating neurodegenerative condition characterized by amyloid beta plaques and tau neurofibrillary tangles, which leads to progressive cognitive decline. Several new mouse models of fast amyloid deposition have been generated with compound mutations, but how these affect high-level cognitive function is still not fully understood. Four cohorts of a second-generation amyloid precursor protein knock-in mouse model, AppNL-G-F/NL-G-F, which develops aggressive amyloidopathy, were compared with two different control groups that do not produce plaques (AppNL/NL and wildtype littermates), on touchscreen-based tests of learning and cognitive flexibility. AppNL-G-F/NL-G-F mice learned to discriminate between two visual stimuli during the pairwise visual discrimination (PVD) task but were impaired when the reward contingencies were reversed (the PVR task). Analyses of the correction trials indicated perseverative behavior. One cohort was further tested on the touchscreen Extinction test, which isolates the ability to withhold responding to a previously rewarded stimulus. The AppNL-G-F/NL-G-F mice extinguished their responding no differently than the AppNL/NL control group. These results indicate that compound mutations in App driving fast accumulation of plaques in this mouse model impair cognitive flexibility and may serve as a preclinical target for putative therapeutic drugs.Alzheimer's disease is a debilitating neurodegenerative condition characterized by amyloid beta plaques and tau neurofibrillary tangles, which leads to progressive cognitive decline. Several new mouse models of fast amyloid deposition have been generated with compound mutations, but how these affect high-level cognitive function is still not fully understood. Four cohorts of a second-generation amyloid precursor protein knock-in mouse model, AppNL-G-F/NL-G-F, which develops aggressive amyloidopathy, were compared with two different control groups that do not produce plaques (AppNL/NL and wildtype littermates), on touchscreen-based tests of learning and cognitive flexibility. AppNL-G-F/NL-G-F mice learned to discriminate between two visual stimuli during the pairwise visual discrimination (PVD) task but were impaired when the reward contingencies were reversed (the PVR task). Analyses of the correction trials indicated perseverative behavior. One cohort was further tested on the touchscreen Extinction test, which isolates the ability to withhold responding to a previously rewarded stimulus. The AppNL-G-F/NL-G-F mice extinguished their responding no differently than the AppNL/NL control group. These results indicate that compound mutations in App driving fast accumulation of plaques in this mouse model impair cognitive flexibility and may serve as a preclinical target for putative therapeutic drugs.
Alzheimer's disease is a debilitating neurodegenerative condition characterized by amyloid beta plaques and tau neurofibrillary tangles, which leads to progressive cognitive decline. Several new mouse models of fast amyloid deposition have been generated with compound mutations, but how these affect high‐level cognitive function is still not fully understood. Four cohorts of a second‐generation amyloid precursor protein knock‐in mouse model, AppNL‐G‐F/NL‐G‐F, which develops aggressive amyloidopathy, were compared with two different control groups that do not produce plaques (AppNL/NL and wildtype littermates), on touchscreen‐based tests of learning and cognitive flexibility. AppNL‐G‐F/NL‐G‐F mice learned to discriminate between two visual stimuli during the pairwise visual discrimination (PVD) task but were impaired when the reward contingencies were reversed (the PVR task). Analyses of the correction trials indicated perseverative behavior. One cohort was further tested on the touchscreen Extinction test, which isolates the ability to withhold responding to a previously rewarded stimulus. The AppNL‐G‐F/NL‐G‐F mice extinguished their responding no differently than the AppNL/NL control group. These results indicate that compound mutations in App driving fast accumulation of plaques in this mouse model impair cognitive flexibility and may serve as a preclinical target for putative therapeutic drugs.
Author Rylett, R. Jane
Bussey, Timothy J.
Yang, Sabrina
Dumont, Julie R.
Saksida, Lisa M.
Sheppard, Paul A. S.
Fodor, Chris
Saito, Takashi
Coto, M. Alexander
Prado, Vania F.
Prado, Marco A. M.
Saido, Takaomi C.
AuthorAffiliation 3 Department of Neurocognitive Science Institute of Brain Science, Nagoya City University Nagoya Aichi Japan
6 Department of Physiology and Pharmacology, Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, Western University BrainsCAN, Robarts Research Institute London Ontario Canada
1 BrainsCAN, Western University London Ontario Canada
4 RIKEN Center for Brain Science Wako, Saitama Japan
5 Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, Western University BrainsCAN, Robarts Research Institute London Ontario Canada
2 Robarts Research Institute, Western University London Ontario Canada
AuthorAffiliation_xml – name: 4 RIKEN Center for Brain Science Wako, Saitama Japan
– name: 1 BrainsCAN, Western University London Ontario Canada
– name: 3 Department of Neurocognitive Science Institute of Brain Science, Nagoya City University Nagoya Aichi Japan
– name: 2 Robarts Research Institute, Western University London Ontario Canada
– name: 5 Department of Physiology and Pharmacology, Schulich School of Medicine & Dentistry, Western University BrainsCAN, Robarts Research Institute London Ontario Canada
– name: 6 Department of Physiology and Pharmacology, Department of Anatomy and Cell Biology, Schulich School of Medicine & Dentistry, Western University BrainsCAN, Robarts Research Institute London Ontario Canada
Author_xml – sequence: 1
  givenname: Julie R.
  orcidid: 0000-0002-2412-306X
  surname: Dumont
  fullname: Dumont, Julie R.
  organization: BrainsCAN, Western University
– sequence: 2
  givenname: Paul A. S.
  orcidid: 0000-0001-7432-1446
  surname: Sheppard
  fullname: Sheppard, Paul A. S.
  email: psheppa5@uwo.ca
  organization: Robarts Research Institute, Western University
– sequence: 3
  givenname: Chris
  surname: Fodor
  fullname: Fodor, Chris
  organization: BrainsCAN, Western University
– sequence: 4
  givenname: M. Alexander
  surname: Coto
  fullname: Coto, M. Alexander
  organization: BrainsCAN, Western University
– sequence: 5
  givenname: Sabrina
  orcidid: 0000-0003-4880-051X
  surname: Yang
  fullname: Yang, Sabrina
  organization: BrainsCAN, Western University
– sequence: 6
  givenname: Takashi
  orcidid: 0000-0002-9659-9251
  surname: Saito
  fullname: Saito, Takashi
  organization: Institute of Brain Science, Nagoya City University
– sequence: 7
  givenname: Takaomi C.
  orcidid: 0000-0003-1970-6903
  surname: Saido
  fullname: Saido, Takaomi C.
  organization: RIKEN Center for Brain Science
– sequence: 8
  givenname: R. Jane
  orcidid: 0000-0002-9158-9599
  surname: Rylett
  fullname: Rylett, R. Jane
  organization: BrainsCAN, Robarts Research Institute
– sequence: 9
  givenname: Marco A. M.
  orcidid: 0000-0002-3028-5778
  surname: Prado
  fullname: Prado, Marco A. M.
  organization: BrainsCAN, Robarts Research Institute
– sequence: 10
  givenname: Timothy J.
  orcidid: 0000-0002-3180-3709
  surname: Bussey
  fullname: Bussey, Timothy J.
  organization: BrainsCAN, Robarts Research Institute
– sequence: 11
  givenname: Lisa M.
  orcidid: 0000-0002-8416-8171
  surname: Saksida
  fullname: Saksida, Lisa M.
  organization: BrainsCAN, Robarts Research Institute
– sequence: 12
  givenname: Vania F.
  orcidid: 0000-0003-4994-6393
  surname: Prado
  fullname: Prado, Vania F.
  organization: BrainsCAN, Robarts Research Institute
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40455650$$D View this record in MEDLINE/PubMed
BookMark eNp1kc9u1DAQxi1URP9x4AWQJS5w2NZ2nMQ5oXZFy4pF5dAKbpbjTHZdHHtrJwu5IB6BZ-RJ8LLtCpDwwR5pfvPNjL9DtOe8A4SeUXJC0zld1PVJSQjjj9ABLQidUJF92tvFXOyjwxhvCaFlJugTtM8Jz_MiJwfo26xbKROgwVO_cKY3a8AXFr6a2ljTj_ij6Zf4Q4AIYZ2gOajgjFtg47By-KwbrTfNBtBDiD6kyPeQku-c159_fv8xc_i9HyKkuwGLfftQ41eqX47H6HGrbISn9-8Rurl4cz19O5lfXc6mZ_OJ5qTgk7ZsWCl0Q0SbCVI1TNcVz0Hztmkh51nJ8sQVwNNaSikhKsraomBCK6XTv2RH6PVWdzXUHTQaXB-UlatgOhVG6ZWRf2ecWcqFX0vKKKsIL5PCy3uF4O8GiL3sTNRgrXKQFpQZoznL8tQ0oS_-QW_9EFzaL1FMVKLk5Wak53-OtJvlwZsEvNoCOvgYA7Q7hBK58V0m3-Vv3xN7umW_GAvj_0F5eX6-rfgF_4WwKA
Cites_doi 10.1007/s004060050101
10.1016/j.brainresbull.2012.02.007
10.7554/eLife.49630
10.1186/s13041‐020‐00690‐6
10.1096/fj.201802108R
10.3389/fnbeh.2025.1536458
10.1111/gbb.12695
10.1016/j.neurobiolaging.2018.10.026
10.1038/nature11283
10.1016/j.jalz.2011.03.005
10.1136/jnnp.60.1.91
10.1016/0031‐9384(74)90154‐1
10.1101/lm.1041309
10.3233/JAD‐180410
10.1016/0301‐0082(94)90039‐6
10.1177/153331750502000607
10.1038/s41598‐019‐51928‐w
10.1038/nprot.2013.123
10.1093/cercor/bhv332
10.1002/hipo.22999
10.1111/gbb.12650
10.15252/emmm.201606210
10.1523/JNEUROSCI.4904‐07.2008
10.1016/S0140‐6736(15)01124‐1
10.1007/7854_2015_5007
10.1038/nn.3697
10.1016/0165-6147(91)90609-V
10.1186/s12868‐018‐0446‐8
10.1016/j.bbr.2017.11.017
10.1038/nprot.2013.122
10.1111/gbb.12664
10.1016/j.nlm.2016.07.001
10.1016/j.nbd.2017.10.014
10.1037/h0028956
10.1523/JNEUROSCI.23‐25‐08771.2003
10.1037/0894‐4105.6.3.211
10.1037//0735‐7044.115.4.957
10.1002/eji.201142048
10.1111/ejn.14500
10.1002/gps.2452
10.1016/j.neurobiolaging.2021.08.004
10.1016/j.acn.2005.07.002
10.1016/S0028‐3932(99)00079‐2
10.1016/j.pnpbp.2007.01.011
10.15252/embj.201797397
10.1186/s12868‐019‐0496‐6
10.3389/fnbeh.2019.00092
10.1021/cn500105p
10.1016/j.neurobiolaging.2012.08.006
10.1038/s41573‐022‐00391‐w
10.1016/j.nlm.2021.107443
10.1038/nn.2954
10.1016/s0010‐9452(08)70785‐8
10.1007/s12031‐016‐0837‐1
10.1016/j.bbr.2017.09.006
ContentType Journal Article
Copyright 2025 The Author(s). published by International Behavioural and Neural Genetics Society and John Wiley & Sons Ltd.
2025 The Author(s). Genes, Brain and Behavior published by International Behavioural and Neural Genetics Society and John Wiley & Sons Ltd.
2025. This work is published under Creative Commons Attribution – Non-Commercial License~http://creativecommons.org/licenses/by-nc/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2025 The Author(s). published by International Behavioural and Neural Genetics Society and John Wiley & Sons Ltd.
– notice: 2025 The Author(s). Genes, Brain and Behavior published by International Behavioural and Neural Genetics Society and John Wiley & Sons Ltd.
– notice: 2025. This work is published under Creative Commons Attribution – Non-Commercial License~http://creativecommons.org/licenses/by-nc/3.0/ (the "License"). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7TK
8FD
FR3
P64
RC3
7X8
5PM
DOI 10.1111/gbb.70024
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Animal Behavior Abstracts
Neurosciences Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Engineering Research Database
Technology Research Database
Neurosciences Abstracts
Animal Behavior Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitleList CrossRef

MEDLINE

MEDLINE - Academic
Genetics Abstracts
Database_xml – sequence: 1
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Anatomy & Physiology
EISSN 1601-183X
EndPage n/a
ExternalDocumentID PMC12129047
40455650
10_1111_gbb_70024
GBB70024
Genre researchArticle
Journal Article
GrantInformation_xml – fundername: Canada First Research Excellence Fund
GroupedDBID ---
.3N
.GA
.Y3
05W
0R~
10A
1OC
24P
29H
31~
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAFWJ
AAMMB
AAONW
AAZKR
ABCQN
ABCUV
ABDBF
ABEML
ABIVO
ABPVW
ACAHQ
ACCMX
ACFBH
ACGFO
ACGFS
ACMXC
ACPOU
ACPRK
ACSCC
ACUHS
ACXQS
ADBBV
ADEOM
ADIYS
ADIZJ
ADKYN
ADMGS
ADOZA
ADPDF
ADXAS
ADZMN
AEFGJ
AEIMD
AENEX
AFBPY
AFEBI
AFGKR
AFKRA
AFZJQ
AGXDD
AIACR
AIDQK
AIDYY
AIURR
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMBMR
AMYDB
ATUGU
AZBYB
AZVAB
BAFTC
BAWUL
BBNVY
BENPR
BFHJK
BHBCM
BHPHI
BMXJE
BROTX
BRXPI
BY8
CAG
CCPQU
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EAD
EAP
EBD
EBS
EJD
EMB
EMK
EMOBN
ESX
F00
F01
F04
F5P
FUBAC
G-S
G.N
GODZA
H.X
HCIFZ
HF~
HZ~
IHE
IX1
J0M
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
M7P
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OIG
OK1
OVD
OVEED
P2P
P2W
P2X
P2Z
P4B
P4D
PGMZT
PHGZM
PHGZT
PQGLB
PSYQQ
PUEGO
Q.N
Q11
QB0
R.K
ROL
RPM
RX1
SUPJJ
SV3
TEORI
TUS
UB1
V8K
W8V
W99
WBKPD
WIH
WIJ
WIK
WIN
WNSPC
WOHZO
WQJ
WXI
WYISQ
XG1
YFH
YUY
ZZTAW
~IA
~WT
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QG
7TK
8FD
FR3
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c4064-f7d278cd08f3809d2cb945ec4fdfe5437254066e4455aaa88912f6628caac0243
IEDL.DBID DR2
ISSN 1601-1848
1601-183X
IngestDate Thu Aug 21 18:24:40 EDT 2025
Fri Sep 05 15:58:04 EDT 2025
Sun Jul 27 14:56:44 EDT 2025
Mon Jul 21 06:01:06 EDT 2025
Thu Jul 03 08:21:39 EDT 2025
Tue Sep 09 05:12:27 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords reversal learning
APP
executive dysfunction
extinction
pairwise visual discrimination
Language English
License Attribution-NonCommercial
2025 The Author(s). Genes, Brain and Behavior published by International Behavioural and Neural Genetics Society and John Wiley & Sons Ltd.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4064-f7d278cd08f3809d2cb945ec4fdfe5437254066e4455aaa88912f6628caac0243
Notes This work was supported by Canada First Research Excellence Fund.
Julie R. Dumont and Paul A. S. Sheppard are Co‐first authors.
Funding
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
Funding: This work was supported by Canada First Research Excellence Fund.
ORCID 0000-0002-3028-5778
0000-0001-7432-1446
0000-0002-9659-9251
0000-0002-8416-8171
0000-0003-4994-6393
0000-0002-3180-3709
0000-0003-4880-051X
0000-0003-1970-6903
0000-0002-9158-9599
0000-0002-2412-306X
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fgbb.70024
PMID 40455650
PQID 3228987474
PQPubID 1066353
PageCount 15
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_12129047
proquest_miscellaneous_3215235662
proquest_journals_3228987474
pubmed_primary_40455650
crossref_primary_10_1111_gbb_70024
wiley_primary_10_1111_gbb_70024_GBB70024
PublicationCentury 2000
PublicationDate June 2025
PublicationDateYYYYMMDD 2025-06-01
PublicationDate_xml – month: 06
  year: 2025
  text: June 2025
PublicationDecade 2020
PublicationPlace Oxford, UK
PublicationPlace_xml – name: Oxford, UK
– name: England
– name: Malden
PublicationTitle Genes, brain and behavior
PublicationTitleAlternate Genes Brain Behav
PublicationYear 2025
Publisher Blackwell Publishing Ltd
John Wiley & Sons, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: John Wiley & Sons, Inc
References 1974; 12
2021; 20
2019; 50
1991; 12
2019; 13
2016; 388
2005; 20
2020; 13
2022; 21
2011; 14
1970; 71
1999; 249
2012; 488
2007; 31
2013; 8
2001; 47
2019; 364
1992; 6
2014; 5
2010; 25
2019; 20
2017; 36
2018; 336
2006; 21
2008; 28
1996; 60
2019; 29
2014; 17
2009; 16
2019; 8
2019; 9
2019; 75
2019; 33
2021; 108
2021; 182
2025; 19
1994; 44
2013; 92
2018; 66
2011; 7
2018; 19
2018; 110
2000; 38
2013; 34
2016; 135
1999; 35
2016; 60
2016; 28
2016; 27
2016; 8
2001; 115
2012; 42
2003; 23
e_1_2_8_28_1
e_1_2_8_24_1
e_1_2_8_47_1
e_1_2_8_26_1
e_1_2_8_49_1
Collette F. (e_1_2_8_37_1) 2001; 47
e_1_2_8_3_1
e_1_2_8_5_1
e_1_2_8_7_1
e_1_2_8_9_1
e_1_2_8_20_1
e_1_2_8_43_1
e_1_2_8_22_1
e_1_2_8_45_1
e_1_2_8_41_1
e_1_2_8_17_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_36_1
e_1_2_8_15_1
e_1_2_8_38_1
e_1_2_8_57_1
e_1_2_8_32_1
e_1_2_8_55_1
e_1_2_8_11_1
e_1_2_8_34_1
e_1_2_8_53_1
e_1_2_8_51_1
e_1_2_8_30_1
e_1_2_8_29_1
e_1_2_8_25_1
e_1_2_8_46_1
e_1_2_8_27_1
e_1_2_8_48_1
e_1_2_8_2_1
e_1_2_8_4_1
e_1_2_8_6_1
e_1_2_8_8_1
e_1_2_8_21_1
e_1_2_8_42_1
e_1_2_8_23_1
e_1_2_8_44_1
e_1_2_8_40_1
e_1_2_8_18_1
e_1_2_8_39_1
e_1_2_8_14_1
e_1_2_8_35_1
e_1_2_8_16_1
e_1_2_8_58_1
e_1_2_8_10_1
e_1_2_8_31_1
e_1_2_8_56_1
e_1_2_8_12_1
e_1_2_8_33_1
e_1_2_8_54_1
e_1_2_8_52_1
e_1_2_8_50_1
References_xml – volume: 16
  start-page: 279
  issue: 5
  year: 2009
  end-page: 288
  article-title: Extinction Circuits for Fear and Addiction Overlap in Prefrontal Cortex
  publication-title: Learning & Memory
– volume: 60
  start-page: 91
  issue: 1
  year: 1996
  end-page: 93
  article-title: Executive Dysfunction in Early Alzheimer's Disease
  publication-title: Journal of Neurology, Neurosurgery, and Psychiatry
– volume: 20
  start-page: 359
  issue: 6
  year: 2005
  end-page: 366
  article-title: Neurocognitive Testing Supports a Broader Concept of Mild Cognitive Impairment
  publication-title: American Journal of Alzheimer's Disease and Other Dementias
– volume: 28
  start-page: 423
  year: 2016
  end-page: 447
  article-title: Cognitive Translation Using the Rodent Touchscreen Testing Approach
  publication-title: Current Topics in Behavioral Neurosciences
– volume: 8
  start-page: 1961
  issue: 10
  year: 2013
  end-page: 1984
  article-title: The Touchscreen Operant Platform for Testing Learning and Memory in Rats and Mice
  publication-title: Nature Protocols
– volume: 17
  start-page: 661
  year: 2014
  end-page: 663
  article-title: Single App Knock‐In Mouse Models of Alzheimer's Disease
  publication-title: Nature Neuroscience
– volume: 38
  start-page: 252
  issue: 3
  year: 2000
  end-page: 271
  article-title: The Nature and Staging of Attention Dysfunction in Early (Minimal and Mild) Alzheimer's Disease: Relationship to Episodic and Semantic Memory Impairment
  publication-title: Neuropsychologia
– volume: 135
  start-page: 73
  year: 2016
  end-page: 82
  article-title: Cognitive Deficits in Single App Knock‐In Mouse Models
  publication-title: Neurobiology of Learning and Memory
– volume: 488
  start-page: 96
  issue: 7409
  year: 2012
  end-page: 99
  article-title: A Mutation in APP Protects Against Alzheimer's Disease and Age‐Related Cognitive Decline
  publication-title: Nature
– volume: 23
  start-page: 8771
  issue: 25
  year: 2003
  end-page: 8780
  article-title: Dissociable Contributions of the Orbitofrontal and Infralimbic Cortex to Pavlovian Autoshaping and Discrimination Reversal Learning: Further Evidence for the Functional Heterogeneity of the Rodent Frontal Cortex
  publication-title: Journal of Neuroscience
– volume: 20
  issue: 1
  year: 2021
  article-title: Translational Cognitive Neuroscience of Dementia With Touchscreen Operant Chambers
  publication-title: Genes, Brain, and Behavior
– volume: 182
  year: 2021
  article-title: Touchscreen Cognitive Testing: Cross‐Species Translation and Co‐Clinical Trials in Neurodegenerative and Neuropsychiatric Disease
  publication-title: Neurobiology of Learning and Memory
– volume: 60
  start-page: 371
  year: 2016
  end-page: 382
  article-title: Translational Assays for Assessment of Cognition in Rodent Models of Alzheimer's Disease and Dementia
  publication-title: Journal of Molecular Neuroscience
– volume: 7
  start-page: 263
  issue: 3
  year: 2011
  end-page: 269
  article-title: The Diagnosis of Dementia due to Alzheimer's Disease: Recommendations From the National Institute on Aging‐Alzheimer's Association Workgroups on Diagnostic Guidelines for Alzheimer's Disease
  publication-title: Alzheimer's & Dementia
– volume: 388
  start-page: 505
  issue: 10043
  year: 2016
  end-page: 517
  article-title: Alzheimer's Disease
  publication-title: Lancet
– volume: 8
  year: 2019
  article-title: MouseBytes, an Open‐Access High‐Throughput Pipeline and Database for Rodent Touchscreen‐Based Cognitive Assessment
  publication-title: eLife
– volume: 66
  start-page: 801
  issue: 2
  year: 2018
  end-page: 809
  article-title: Increased Insoluble Amyloid‐β Induces Negligible Cognitive Deficits in Old AppNL/NL Knock‐In Mice
  publication-title: Journal of Alzheimer's Disease
– volume: 31
  start-page: 746
  issue: 3
  year: 2007
  end-page: 751
  article-title: Automated Neuropsychological Test Battery (CANTAB) in Mild Cognitive Impairment and in Alzheimer's Disease
  publication-title: Progress in Neuro‐Psychopharmacology & Biological Psychiatry
– volume: 12
  start-page: 1057
  issue: 6
  year: 1974
  end-page: 1061
  article-title: Stimulus Perseveration of Rats With Septal Lesions
  publication-title: Physiology & Behavior
– volume: 71
  start-page: 114
  issue: 1
  year: 1970
  end-page: 118
  article-title: Response and Stimulus Perseveration in Rats With Septal and Dorsal Hippocampal Lesions
  publication-title: Journal of Comparative and Physiological Psychology
– volume: 249
  start-page: 288
  year: 1999
  end-page: 290
  article-title: Clinical Features of Alzheimer's Disease
  publication-title: European Archives of Psychiatry and Clinical Neuroscience
– volume: 92
  start-page: 49
  year: 2013
  end-page: 55
  article-title: Paying More Attention to Attention: Towards More Comprehensive Cognitive Translation Using Mouse Models of Alzheimer's Disease
  publication-title: Brain Research Bulletin
– volume: 6
  start-page: 211
  issue: 3
  year: 1992
  end-page: 224
  article-title: A Neuropsychological Investigation Into Frontal Lobe Involvement in Dementia of the Alzheimer Type
  publication-title: Neuropsychology
– volume: 33
  start-page: 7018
  issue: 6
  year: 2019
  end-page: 7036
  article-title: Selective Decrease of Cholinergic Signaling From Pedunculopontine and Laterodorsal Tegmental Nuclei has Little Impact on Cognition but Markedly Increases Susceptibility to Stress
  publication-title: FASEB Journal
– volume: 21
  start-page: 15
  issue: 1
  year: 2006
  end-page: 21
  article-title: Executive Function Deficits in Early Alzheimer's Disease and Their Relations With Episodic Memory
  publication-title: Archives of Clinical Neuropsychology
– volume: 21
  start-page: 306
  year: 2022
  end-page: 318
  article-title: The Amyloid Hypothesis in Alzheimer Disease: New Insights From New Therapeutics
  publication-title: Nature Reviews Drug Discovery
– volume: 35
  start-page: 57
  issue: 1
  year: 1999
  end-page: 72
  article-title: Executive Dysfunction in Alzheimer's Disease
  publication-title: Cortex
– volume: 14
  start-page: 1507
  issue: 12
  year: 2011
  end-page: 1509
  article-title: Paradoxical Reversal Learning Enhancement by Stress or Prefrontal Cortical Damage: Rescue With BDNF
  publication-title: Nature Neuroscience
– volume: 29
  start-page: 3
  issue: 1
  year: 2019
  end-page: 14
  article-title: Looking Beyond the Standard Version of the Morris Water Task in the Assessment of Mouse Models of Cognitive Deficits
  publication-title: Hippocampus
– volume: 8
  start-page: 1985
  year: 2013
  end-page: 2005
  article-title: The Touchscreen Operant Platform for Assessing Executive Function in Rats and Mice
  publication-title: Nature Protocols
– volume: 115
  start-page: 957
  issue: 4
  year: 2001
  end-page: 960
  article-title: Discrimination of Computer‐Graphic Stimuli by Mice: A Method for the Behavioral Characterization of Transgenic and Gene‐Knockout Models
  publication-title: Behavioral Neuroscience
– volume: 20
  issue: 1
  year: 2021
  article-title: Comparison Between Touchscreen Operant Chambers and Water Maze to Detect Early Prefrontal Dysfunction in Mice
  publication-title: Genes, Brain, and Behavior
– volume: 19
  start-page: 46
  year: 2018
  article-title: Cognitive and Emotional Alterations in App Knock‐In Mouse Models of Aβ Amyloidosis
  publication-title: BMC Neuroscience
– volume: 19
  year: 2025
  article-title: Assessing Cognitive Flexibility in Mice Using a Custom‐Built Touchscreen Chamber
  publication-title: Frontiers in Behavioral Neuroscience
– volume: 5
  start-page: 499
  issue: 7
  year: 2014
  end-page: 502
  article-title: New Mouse Model of Alzheimer's
  publication-title: ACS Chemical Neuroscience
– volume: 9
  start-page: 16363
  issue: 1
  year: 2019
  article-title: Neural Oscillations During Cognitive Processes in an App Knock‐In Mouse Model of Alzheimer's Disease Pathology
  publication-title: Scientific Reports
– volume: 25
  start-page: 1150
  issue: 11
  year: 2010
  end-page: 1158
  article-title: Executive Deficits and Regional Brain Metabolism in Alzheimer's Disease
  publication-title: International Journal of Geriatric Psychiatry
– volume: 44
  start-page: 221
  issue: 2
  year: 1994
  end-page: 231
  article-title: The Psychology of Perseverative and Stereotyped Behaviour
  publication-title: Progress in Neurobiology
– volume: 47
  start-page: 272
  year: 2001
  end-page: 275
  article-title: The Relationships Between Executive Dysfunction and Frontal Hypometabolism in Alzheimer's Disease
  publication-title: Brain and Cognition
– volume: 13
  year: 2019
  article-title: Impaired Reversal Learning in APPPS1‐21 Mice in the Touchscreen Visual Discrimination Task
  publication-title: Frontiers in Behavioral Neuroscience
– volume: 8
  start-page: 595
  issue: 6
  year: 2016
  end-page: 608
  article-title: The Amyloid Hypothesis of Alzheimer's Disease at 25 Years
  publication-title: EMBO Molecular Medicine
– volume: 108
  start-page: 58
  year: 2021
  end-page: 71
  article-title: Progressive Impairments in Executive Function in the APP/PS1 Model of Alzheimer's Disease as Measured by Translatable Touchscreen Testing
  publication-title: Neurobiology of Aging
– volume: 12
  start-page: 383
  year: 1991
  end-page: 388
  article-title: Amyloid Deposition as the Central Event in the Aetiology of Alzheimer's Disease
  publication-title: Trends in Pharmacological Sciences
– volume: 20
  start-page: 13
  issue: 1
  year: 2019
  article-title: Amyloid‐β Plaque Formation and Reactive Gliosis Are Required for Induction of Cognitive Deficits in App Knock‐In Mouse Models of Alzheimer's Disease
  publication-title: BMC Neuroscience
– volume: 50
  start-page: 2773
  issue: 5
  year: 2019
  end-page: 2785
  article-title: The Arctic/Swedish APP Mutation Alters the Impact of Chronic Stress on Cognition in Mice
  publication-title: European Journal of Neuroscience
– volume: 34
  start-page: 731
  issue: 3
  year: 2013
  end-page: 744
  article-title: A Touch Screen‐Automated Cognitive Test Battery Reveals Impaired Attention, Memory Abnormalities, and Increased Response Inhibition in the TgCRND8 Mouse Model of Alzheimer's Disease
  publication-title: Neurobiology of Aging
– volume: 110
  start-page: 29
  year: 2018
  end-page: 36
  article-title: Istradefylline Reduces Memory Deficits in Aging Mice With Amyloid Pathology
  publication-title: Neurobiology of Disease
– volume: 336
  start-page: 177
  year: 2018
  end-page: 181
  article-title: Reduction in Open Field Activity in the Absence of Memory Deficits in the AppNL−G−F Knock‐In Mouse Model of Alzheimer's Disease
  publication-title: Behavioural Brain Research
– volume: 27
  issue: 2
  year: 2016
  article-title: Intraneuronal Amyloid Beta Accumulation Disrupts Hippocampal CRTC1‐Dependent Gene Expression and Cognitive Function in a Rat Model of Alzheimer Disease
  publication-title: Cerebral Cortex
– volume: 42
  start-page: 45
  issue: 1
  year: 2012
  end-page: 47
  article-title: The Need for Littermate Controls
  publication-title: European Journal of Neuroscience
– volume: 36
  start-page: 2473
  year: 2017
  end-page: 2487
  article-title: APP Mouse Models for Alzheimer's Disease Preclinical Studies
  publication-title: EMBO Journal
– volume: 75
  start-page: 25
  year: 2019
  end-page: 37
  article-title: Age‐Dependent Behavioral and Biochemical Characterization of Single APP Knock‐In Mouse (APP ) Model of Alzheimer's Disease
  publication-title: Neurobiology of Aging
– volume: 364
  start-page: 431
  year: 2019
  end-page: 441
  article-title: Subtle Behavioral Changes and Increased Prefrontal‐Hippocampal Network Synchronicity in APP Mice Before Prominent Plaque Deposition
  publication-title: Behavioural Brain Research
– volume: 28
  start-page: 8074
  issue: 32
  year: 2008
  end-page: 8085
  article-title: Impaired Fear Extinction Learning and Cortico‐Amygdala Circuit Abnormalities in a Common Genetic Mouse Strain
  publication-title: Journal of Neuroscience
– volume: 20
  issue: 1
  year: 2021
  article-title: Critical Mass: The Rise of a Touchscreen Technology Community for Rodent Cognitive Testing
  publication-title: Genes, Brain, and Behavior
– volume: 13
  start-page: 147
  year: 2020
  article-title: Touchscreen‐Based Location Discrimination and Paired Associate Learning Tasks Detect Cognitive Impairment at an Early Stage in an App Knock‐In Mouse Model of Alzheimer's Disease
  publication-title: Molecular Brain
– ident: e_1_2_8_3_1
  doi: 10.1007/s004060050101
– ident: e_1_2_8_33_1
  doi: 10.1016/j.brainresbull.2012.02.007
– ident: e_1_2_8_44_1
  doi: 10.7554/eLife.49630
– ident: e_1_2_8_23_1
  doi: 10.1186/s13041‐020‐00690‐6
– ident: e_1_2_8_27_1
  doi: 10.1096/fj.201802108R
– ident: e_1_2_8_43_1
  doi: 10.3389/fnbeh.2025.1536458
– ident: e_1_2_8_47_1
  doi: 10.1111/gbb.12695
– ident: e_1_2_8_25_1
  doi: 10.1016/j.neurobiolaging.2018.10.026
– ident: e_1_2_8_8_1
  doi: 10.1038/nature11283
– ident: e_1_2_8_4_1
  doi: 10.1016/j.jalz.2011.03.005
– ident: e_1_2_8_36_1
  doi: 10.1136/jnnp.60.1.91
– ident: e_1_2_8_51_1
  doi: 10.1016/0031‐9384(74)90154‐1
– ident: e_1_2_8_55_1
  doi: 10.1101/lm.1041309
– ident: e_1_2_8_18_1
  doi: 10.3233/JAD‐180410
– ident: e_1_2_8_52_1
  doi: 10.1016/0301‐0082(94)90039‐6
– ident: e_1_2_8_56_1
  doi: 10.1177/153331750502000607
– ident: e_1_2_8_20_1
  doi: 10.1038/s41598‐019‐51928‐w
– ident: e_1_2_8_31_1
  doi: 10.1038/nprot.2013.123
– ident: e_1_2_8_42_1
  doi: 10.1093/cercor/bhv332
– ident: e_1_2_8_16_1
  doi: 10.1002/hipo.22999
– ident: e_1_2_8_28_1
  doi: 10.1111/gbb.12650
– volume: 47
  start-page: 272
  year: 2001
  ident: e_1_2_8_37_1
  article-title: The Relationships Between Executive Dysfunction and Frontal Hypometabolism in Alzheimer's Disease
  publication-title: Brain and Cognition
– ident: e_1_2_8_10_1
  doi: 10.15252/emmm.201606210
– ident: e_1_2_8_54_1
  doi: 10.1523/JNEUROSCI.4904‐07.2008
– ident: e_1_2_8_5_1
  doi: 10.1016/S0140‐6736(15)01124‐1
– ident: e_1_2_8_29_1
  doi: 10.1007/7854_2015_5007
– ident: e_1_2_8_12_1
  doi: 10.1038/nn.3697
– ident: e_1_2_8_7_1
  doi: 10.1016/0165-6147(91)90609-V
– ident: e_1_2_8_21_1
  doi: 10.1186/s12868‐018‐0446‐8
– ident: e_1_2_8_14_1
  doi: 10.1016/j.bbr.2017.11.017
– ident: e_1_2_8_40_1
  doi: 10.1038/nprot.2013.122
– ident: e_1_2_8_30_1
  doi: 10.1111/gbb.12664
– ident: e_1_2_8_15_1
  doi: 10.1016/j.nlm.2016.07.001
– ident: e_1_2_8_24_1
  doi: 10.1016/j.nbd.2017.10.014
– ident: e_1_2_8_50_1
  doi: 10.1037/h0028956
– ident: e_1_2_8_53_1
  doi: 10.1523/JNEUROSCI.23‐25‐08771.2003
– ident: e_1_2_8_58_1
  doi: 10.1037/0894‐4105.6.3.211
– ident: e_1_2_8_41_1
  doi: 10.1037//0735‐7044.115.4.957
– ident: e_1_2_8_19_1
  doi: 10.1002/eji.201142048
– ident: e_1_2_8_26_1
  doi: 10.1111/ejn.14500
– ident: e_1_2_8_6_1
  doi: 10.1002/gps.2452
– ident: e_1_2_8_2_1
– ident: e_1_2_8_45_1
  doi: 10.1016/j.neurobiolaging.2021.08.004
– ident: e_1_2_8_35_1
  doi: 10.1016/j.acn.2005.07.002
– ident: e_1_2_8_39_1
  doi: 10.1016/S0028‐3932(99)00079‐2
– ident: e_1_2_8_57_1
  doi: 10.1016/j.pnpbp.2007.01.011
– ident: e_1_2_8_13_1
  doi: 10.15252/embj.201797397
– ident: e_1_2_8_17_1
  doi: 10.1186/s12868‐019‐0496‐6
– ident: e_1_2_8_46_1
  doi: 10.3389/fnbeh.2019.00092
– ident: e_1_2_8_11_1
  doi: 10.1021/cn500105p
– ident: e_1_2_8_48_1
  doi: 10.1016/j.neurobiolaging.2012.08.006
– ident: e_1_2_8_9_1
  doi: 10.1038/s41573‐022‐00391‐w
– ident: e_1_2_8_32_1
  doi: 10.1016/j.nlm.2021.107443
– ident: e_1_2_8_49_1
  doi: 10.1038/nn.2954
– ident: e_1_2_8_38_1
  doi: 10.1016/s0010‐9452(08)70785‐8
– ident: e_1_2_8_34_1
  doi: 10.1007/s12031‐016‐0837‐1
– ident: e_1_2_8_22_1
  doi: 10.1016/j.bbr.2017.09.006
SSID ssj0017381
Score 2.428674
Snippet ABSTRACT Alzheimer's disease is a debilitating neurodegenerative condition characterized by amyloid beta plaques and tau neurofibrillary tangles, which leads...
Alzheimer's disease is a debilitating neurodegenerative condition characterized by amyloid beta plaques and tau neurofibrillary tangles, which leads to...
SourceID pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage e70024
SubjectTerms Alzheimer Disease - genetics
Alzheimer's disease
Amyloid beta-Protein Precursor - genetics
Amyloid beta-Protein Precursor - metabolism
Amyloid precursor protein
Animal models
Animals
APP
Cognition - physiology
Cognitive ability
Cognitive Flexibility
Disease Models, Animal
executive dysfunction
extinction
Female
Flexibility
Gene Knock-In Techniques
Interactive computer systems
Learning - physiology
Male
Mice
Mice, Transgenic
Mutation
Neurodegenerative diseases
Neurofibrillary tangles
Original
pairwise visual discrimination
Plaque, Amyloid
Protein structure
reversal learning
Senile plaques
Tau protein
Visual discrimination
Visual stimuli
Title Impaired Cognitive Flexibility With Preserved Learning in an Amyloid Precursor Protein Knock‐In Mouse Model of Amyloidopathy
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fgbb.70024
https://www.ncbi.nlm.nih.gov/pubmed/40455650
https://www.proquest.com/docview/3228987474
https://www.proquest.com/docview/3215235662
https://pubmed.ncbi.nlm.nih.gov/PMC12129047
Volume 24
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1601-183X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017381
  issn: 1601-1848
  databaseCode: ABDBF
  dateStart: 20030201
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1601-183X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017381
  issn: 1601-1848
  databaseCode: RPM
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
– providerCode: PRVOVD
  databaseName: Journals@Ovid LWW All Open Access Journal Collection Rolling
  customDbUrl:
  eissn: 1601-183X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017381
  issn: 1601-1848
  databaseCode: OVEED
  dateStart: 20020101
  isFulltext: true
  titleUrlDefault: http://ovidsp.ovid.com/
  providerName: Ovid
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl: http://www.proquest.com/pqcentral?accountid=15518
  eissn: 1601-183X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017381
  issn: 1601-1848
  databaseCode: BENPR
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 1601-1848
  databaseCode: DR2
  dateStart: 20020101
  customDbUrl:
  isFulltext: true
  eissn: 1601-183X
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0017381
  providerName: Wiley-Blackwell
– providerCode: PRVWIB
  databaseName: Wiley Online Library Open Access
  customDbUrl:
  eissn: 1601-183X
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0017381
  issn: 1601-1848
  databaseCode: 24P
  dateStart: 20220101
  isFulltext: true
  titleUrlDefault: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VcuFCgfLYUlYGIcQlq8TrxI447VZdWhBVVVHRA1JkO3a7onVQd_ewHBA_gd_YX9Kx81CXCglxi2RHec2Mvxl_-Qbgdcq5VrEykVUsjlhudSSNySORWZZRxhVVgSB7kO0dsw8n6ckavGv_han1IbqCm_eMEK-9g0s1u-Hkp0oNuF9iMP4mwzRs0R510lEJH4YGpQkmHBFmMaJRFfIsnu7M1bXoFsC8zZO8iV_DAjTZgK_trde8k2-DxVwN9I8_VB3_89kewP0GmJJRbUkPYc24R7A5cpiUXyzJGxKooqEGvwk_9zGIYKwsyU7LPiITr6wZmLZL8mU6PyOe3OHplCVpNFxPydQR6cjoYnleTUs_QS8Q71_iUeWbbpKPDqPz1a_f-458qhYzQ3yntnNS2facyjdQXj6G48nu5529qGnkEGnECyyyvKRc6DIWdijivKRa5Sw1mtnSmtTvHCJuzDLDWJpKKYXIE2qzjAotpfaSiU9g3VXOPANCrTQ6K1OqSkwsucoRoSCCZZwaNDFGe_Cq_aTF91qvo2jzHHyrRXirPdhuP3bRuOyswMgmcoHZFQ6_7IbR2fwOinQGHxvnINxBW8vwOk9r2-iuwhAcIzqOeyBWrKab4IW8V0fc9CwIeifUVwMZ78HbYBV_v_Pi_XgcDrb-fepzuEd90-JQOtqG9fnlwrxAJDVXfbhD2WEf7o53Dw6P-sGB-qHgdQ0pXh_s
linkProvider Wiley-Blackwell
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1Lb9QwEB6VcoALAspj-wCDEOISlPU6sSP1sq1YdulDHFrRWxS_2pWog9rdw14QP4Hf2F_SGW8SdVUhcYtkO04yr2_GkxmAD5mURqfaJV6LNBGFN0nlXJGo3IucC6m5jgmyx_n4VHw7y87WYLf9F2ZZH6ILuJFkRH1NAk4B6TtSfq71Z0k25gE8xPumxNNcfO_OEOQgtijto8uRoB-jmrpClMfTLV21Rvcg5v1MybsINpqg0VN40mBHNlwS-xmsufAcNoYB_ebLBfvIYjZnDJNvwO8JyjmqM8v22wQhNqLilzEZdsF-TGcXjPIvKOPRsqbM6jmbBlYFNrxEP35qaYKZIyS_wqua-mKyg4AK9ObP30lgR_X82jFqpvaT1b5dU1OP48ULOB19OdkfJ02vhcSgSReJl5ZLZWyq_EClheVGFyJzRnjrXUaHewjt8twJkWVVVSlV9LnPc65MVRmqavgS1kMd3Gtg3FfO5Dbj2qLvJ3WBIAJBppDcIRcI3oP37Tcvfy1LapStK4KEKSNherDdUqNspOq6ROWjCoUOEA6_64ZRHuiQowoOXxvnICIZIEjFfV4tidftIhC_IoBNe6BWyNpNoFrbqyNhehFrbvc5BeyE7MGnyAH_fvLy695evNj8_6lv4dH45OiwPJwcH2zBY049hmOkZxvWZ1dzt4PAZ6bfRP6-BZHY_9s
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1baxQxFD7UCuKLt3rZWjWKiC-zzGYzkww-batr12oRsdgHYci1XdpmSrv7sD6IP8Hf6C_xJHOhaxHEt4EkZC7nnHwn-eY7AM8zzrVKlU2cYmnCCqcTaW2RiNyxnDKuqIoE2d18e4-928_2V-BV-y9MrQ_RbbgFz4jxOjj4qXEXnPxAqT4PS8wVuMpyzK4CIvrUaUcN-DBWKB1gxpFgGiMaWaFA4-mGLi9GlxDmZaLkRQAbV6DxTfja3ntNPDnqz2eqr7_9Iev4nw93C240yJSMalO6DSvW34G1kces_GRBXpDIFY2b8GvwfYJRBIOlIVst_YiMg7RmpNouyJfp7JAEdkfgUxrSiLgekKkn0pPRyeK4mprQQc8R8J_hVRWqbpIdj-H514-fE08-VPNzS0KptmNSuXZMFSooL-7C3vjN563tpKnkkGgEDCxx3FAutEmFG4q0MFSrgmVWM2eczcLRIQLHPLeMZZmUUohiQF2eU6Gl1EEz8R6s-srbB0Cok1bnJqPKYGbJVYEQBSEs49SijTHag2ftJy1Pa8GOsk108K2W8a32YKP92GXjs-clhjZRCEyvsPlp14zeFo5QpLf42NgH8c4QITDOc7-2jW4WhugY4XHaA7FkNV2HoOS93OKnh1HRe0DDdiDjPXgZreLvd16-3dyMF-v_3vUJXPv4ely-n-zuPITrNBQwjttIG7A6O5vbR4iqZupx9J7fCBQfNg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impaired+Cognitive+Flexibility+With+Preserved+Learning+in+an+Amyloid+Precursor+Protein+Knock-In+Mouse+Model+of+Amyloidopathy&rft.jtitle=Genes%2C+brain+and+behavior&rft.au=Dumont%2C+Julie+R&rft.au=Sheppard%2C+Paul+A+S&rft.au=Fodor%2C+Chris&rft.au=Coto%2C+M+Alexander&rft.date=2025-06-01&rft.issn=1601-183X&rft.eissn=1601-183X&rft.volume=24&rft.issue=3&rft.spage=e70024&rft_id=info:doi/10.1111%2Fgbb.70024&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1601-1848&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1601-1848&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1601-1848&client=summon